Ignite Creation Date:
2024-05-06 @ 12:32 PM
Last Modification Date:
2024-10-26 @ 1:00 PM
Study NCT ID:
NCT03789617
Status:
RECRUITING
Last Update Posted:
2022-07-11
First Post:
2018-12-27
Brief Title:
A Multi-center Single-arm Open Phase IIIa Clinical Trial to Evaluate the Efficacy and Safety of EBViNT Cell EBV Specific Autologous CD8 T Cell in Patients With Treatment Failed Epstein Barr Virus EBV-Positive Malignancies
Sponsor:
Organization:
Eutilex
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
72
Enrollment Type:
ESTIMATED
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE1 |
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: